JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5051
Crawford & Co Class A
CRD.A
$532M
| $143K | ﹤0.01% |
12,863
+508
| +4% | +$4.9K |
|
|
CCRD
5052
DELISTED
CoreCard
CCRD
| $143K | ﹤0.01% |
5,620
-15,396
| -73% | -$397K |
|
5053
Oak Valley Bancorp
OVLY
$285M
| $142K | ﹤0.01% |
5,636
-6,556
| -54% | -$159K |
|
5054
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.54B
| $142K | ﹤0.01% |
+6,613
| New | +$146K |
|
5055
ProShares UltraShort Euro
EUO
$34.7M
| $141K | ﹤0.01% |
4,850
-2,071
| -30% | -$60.1K |
|
5056
Zevra Therapeutics
ZVRA
$562M
| $141K | ﹤0.01% |
27,674
+26,896
| +3,457% | +$145K |
|
5057
Purple Innovation
PRPL
$35.3M
| $141K | ﹤0.01% |
2,029
+49
| +2% | +$3.53K |
|
|
PHLT
5058
DELISTED
Performant Healthcare Inc
PHLT
| $141K | ﹤0.01% |
+52,183
| New | +$151K |
|
5059
BlackRock MuniYield New York Quality Fund
MYN
$374M
| $141K | ﹤0.01% |
13,879
+12,072
| +668% | +$121K |
|
5060
PUT
Wingstop
WING
$3.53B
| $140K | ﹤0.01% |
700
-200
| -22% | -$39.1K |
|
5061
Rallybio
RLYB
$84.5M
| $140K | ﹤0.01% |
3,085
-835
| -21% | -$40.9K |
|
5062
Lands' End
LE
$370M
| $139K | ﹤0.01% |
17,974
+6,207
| +53% | +$50.1K |
|
5063
Hippo Holdings
HIPO
$830M
| $139K | ﹤0.01% |
8,436
-5,029
| -37% | -$87.2K |
|
5064
ALX Oncology
ALXO
$261M
| $139K | ﹤0.01% |
18,556
+749
| +4% | +$4.9K |
|
|
MAGN
5065
Magnera Corp
MAGN
$472M
| $139K | ﹤0.01% |
3,537
-545
| -13% | -$24.7K |
|
|
GRTS
5066
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $139K | ﹤0.01% |
71,127
+35,951
| +102% | +$84.2K |
|
|
JBIO
5067
Jade Biosciences
JBIO
$1.2B
| $138K | ﹤0.01% |
231
+29
| +14% | +$18.5K |
|
|
VIEW
5068
DELISTED
View, Inc. Class A Common Stock
VIEW
| $138K | ﹤0.01% |
19,032
+17,271
| +981% | +$260K |
|
5069
Direxion Daily Real Estate Bull 3X ETF
DRN
$45.7M
| $138K | ﹤0.01% |
14,500
+5,000
| +53% | +$45.1K |
|
5070
Ponce Financial Group
PDLB
$488M
| $138K | ﹤0.01% |
15,887
-33,437
| -68% | -$261K |
|
5071
First Western Financial
MYFW
$304M
| $138K | ﹤0.01% |
7,418
-26,006
| -78% | -$456K |
|
5072
Global Water Resources
GWRS
$206M
| $137K | ﹤0.01% |
10,810
-1,428
| -12% | -$16.9K |
|
5073
CVRx
CVRX
$137M
| $137K | ﹤0.01% |
+8,863
| New | +$108K |
|
5074
C&F Financial
CFFI
$268M
| $137K | ﹤0.01% |
+2,547
| New | +$135K |
|
5075
Kaltura
KLTR
$206M
| $136K | ﹤0.01% |
64,366
+62,352
| +3,096% | +$116K |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.